Login
Immune Interventions

Vaccines elicit immunity against pathogenic microbes, and this response can also be exploited to disrupt immune tolerance of cancers. Immune interventions combat autoimmune defects and immune rejection during organ transplantation. Cell- and gene-based therapies target microbial infections, cancers, or treat autoimmune conditions.

104987-11-3
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
CAS No: 104987-11-3
MW: 804.0182
Purity: 98%
Pricing and Availability
288-32-4
1H-Imidazole
CAS No: 288-32-4
MW: 68.0773
Purity: 98%
Pricing and Availability